Overview
Denmark medical cannabis supplier's Q1 net sales rose sharply yr/yr and 15% from Q4
Q1 EBITDA positive for fourth consecutive quarter after CannGros integration
Outlook
Company did not provide specific guidance for future quarters or the full year in press release
Result Drivers
CANNGROS INTEGRATION - Co said integration of CannGros contributed to sales growth and was completed without additional costs or resources
GERMANY EXPANSION - Launch of ASTRUM 10-10 oil in Germany through partner WEECO Pharma supported sales growth
Company press release: ID:nWkr7hzNGC
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
DKK 3.003 mln
Q1 EPS
-DKK 0.01
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)